Kinshasa: A major clinical trial to evaluate vaccines against the Bundibugyo Ebola virus began Friday in the eastern Democratic Republic of the Congo (DRC), with the first participants vaccinated as the country battles the largest recorded outbreak of the virus. The Phase 2/3 trial, known as Tumaini, was launched in Bunia, the capital of the.
